SEARCH   
MEMBER LOGIN    

Pain Medication OTC Manufacturing in Australia: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Pain Medication OTC Manufacturing Market Research Report | Life Sciences | OTC Medicines | Jun 2014

Growth pains: Tighter regulatory controls constrain industry revenue growth

IBISWorld’s Pain Medication OTC Manufacturing market research report can be used to help you: understand market size and growth potential; major companies; draft business plans and pitch books; and conduct benchmarking and SWOT analysis. Our industry analysis highlights macro industry trends in the overall sector and micro trends faced by companies that do business in the industry. The industry report also provides key industry statistics and 5-year forecasts to anticipate future industry prospects so you can decide with confidence.

Report Snapshot
Market Share of Companies
GlaxoSmithKline GlaxoSmithKline market share
Pfizer Australia Pfizer Australia market share
Industry Statistics & Market Size
Revenue
$810m
Annual Growth 09-14
1.3%
Annual Growth 14-19
Purchase to read more
Profit
Purchase to read more
Employment
1,530
Businesses
29
Industry Analysis & Industry Trends

The Pain Medication OTC Manufacturing industry manufactures over-the-counter pharmaceutical products that focus on pain relief and are available without a doctor's prescription. As Australian consumers have a high awareness of self-medication uses, domestic demand for OTC pain medication has remained healthy over the past five years. Consumers are able to reach for an increasing range of pain relief products from their pharmacy and supermarket aisles.

As with other segments of the Pharmaceutical Product Manufacturing industry, the Pain Medication OTC Manufacturing industry is dominated by global players and brand names... purchase to read more

Industry Report - Industry Investment Chapter

Compared with the overall Pharmaceutical Product Manufacturing industry, the Pain Medication OTC Manufacturing industry is relatively less capital intensive as it does not have the same need for facilities capable of producing high-cost, high technology drugs.

Nevertheless it still has a moderate level of capital intensity with capital used to build and maintain manufacturing, formulation and packaging facilities.

At the same time, the industry has a relatively high level of labour intensity, as the manufacturing processes involve highly skilled labour. In 2013-14 the industry will spend $6.90 on labour for each dollar spent on capital investments... purchase to read more

 


Industry ProductsRelated ReportsTable of Contents

What is the Pain Medication OTC Manufacturing Industry?

Companies in this industry research and develop over-the-counter pain relief medicines. Products manufactured by the industry are available without a prescription via pharmacy and grocery channels. Narcotic and opioid analgesics dispensed via prescription are not included in the industry.

Industry Products
SalicylatesPropionic acid derivativesAcetaminophensOther non-steroidal anti-inflammatory drugs
 
Industry Activities
Manufacturing acetaminophen based pain suppressantsManufacturing non-steroidal anti-inflammatory based pain suppressantsManufacturing acetaminophen based pain suppressantsManufacturing non-steroidal anti-inflammatory based pain suppressants


View Sample
Quote
Select Clients